3-(1,3-Benzodioxol-5-yl)-1-phenyl­prop-2-en-1-one by Yathirajan, H. S. et al.
organic papers
Acta Cryst. (2006). E62, o3629–o3630 doi:10.1107/S160053680602767X Yathirajan et al.  C16H12O3 o3629
Acta Crystallographica Section E
Structure Reports
Online
ISSN 1600-5368
3-(1,3-Benzodioxol-5-yl)-1-phenylprop-2-en-1-one
H. S. Yathirajan,a B. K. Sarojini,b
B. Narayana,c S. Bindyad and
Michael Boltee*
aDepartment of Studies in Chemistry, University
of Mysore, Manasagangotri, Mysore 570 006,
India, bDepartment of Chemistry, P. A. College
of Engineering, Nadupadavu, Mangalore 574
153, India, cDepartment of Chemistry, Manga-
lore University, Mangalagangotri 574 199,
India, dDepartment of Chemistry, Sri Jayacha-
marajendra College of Engineering, Manasa-
gangotri, Mysore 570 006, India, and eInstitut
fu¨r Anorganische Chemie, J. W. Goethe-
Universita¨t Frankfurt, Marie-Curie-Strasse 11,
60439 Frankfurt/Main, Germany
Correspondence e-mail:
bolte@chemie.uni-frankfurt.de
Key indicators
Single-crystal X-ray study
T = 173 K
Mean (C–C) = 0.001 A˚
R factor = 0.034
wR factor = 0.092
Data-to-parameter ratio = 16.3
For details of how these key indicators were
automatically derived from the article, see
http://journals.iucr.org/e.
Received 14 July 2006
Accepted 17 July 2006
# 2006 International Union of Crystallography
All rights reserved
In the title biologically active compound, C16H12O3, the
central C C double bond is trans configured. The molecule
consists of two essentially planar parts which are twisted by
26.89 (5) with respect to each other.
Comment
Chalcones possess a broad spectrum of biological activities,
including antibacterial, antihelmintic, amoebicidal, anti-ulcer,
antiviral, insecticidal, antiprotzoal, anticancer, cytotoxic and
immunosuppressive activities (Dimmock et al., 1999). Certain
chalcone derivatives were reported to inhibit the poly-
merization of tubulin to form microtubules and were therefore
antimitotic agents which can be used as anti-inflammatory
agents. Chalcone derivatives were also reported to inhibit the
destruction of myelin sheath in the central nervous system of
multiple sclerosis patients and were thus useful in controlling
the progressive nature of the disease (Edwards et al., 1989).
Chalcones can be easily obtained from the aldol condensation
of aromatic aldehydes and aromatic ketones. This class of
compounds presents interesting biological properties, such as
cytotoxicity (Lawrence et al., 2001), antiherpes activity and
antitumour activity and may be useful for the chemotherapy of
leishmaniasis (Pandey et al., 2005), among others. A compar-
ison of the supramolecular structures of 1-(6-amino-1,3-
benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
and 1-(6-amino-1,3-benzodioxol-5-yl)-3-[4-(N,N-dimethyl-
amino)phenyl]prop-2-en-1-one has been described previously
(Low et al., 2002). The crystal structure of (1,3-benzodioxol-5-
ylmethyl)ammonium 2-methoxy-5-[(1E)-3-oxo-3-phenylprop-
1-en-1-yl]benzenesulfonate monohydrate (da Silva et al., 2006)
has recently been reported. In view of the importance of the
title compound, (I), its crystal structure is reported here.
The molecular structure of the title compound is shown in
Fig. 1. Bond lengths and angles can be regarded as normal
(Cambridge Crystallographic Database, Version 5.27,
November 2005 updated May 2006; Mogul Version 1.1; Allen,
2002). The central C C double bond is trans configured. The
molecule consists of two planar segments which are twisted by
26.89 (5) with respect to each other. One of these contains the
1,2-(methylenedioxy)benzene group which is coplanar with
the propenone group (r.m.s. deviation for all non H atoms
0.049 A˚), and the other segment is the phenyl ring. All torsion
angles are close to 0 or 180; only those about the C10—C11
bond differ significantly from planarity (Table 1). The crystal
packing shows a herringbone pattern (Fig. 2) and reveals one
weak C—H  O contact (Table 2).
Experimental
The title compound was synthesized according to the method
reported in the literature (Vogel, 1989) with a yield of 75%. The
compound was purified by recrystallization from ethanol. The crystal
growth was performed in acetone solvent by slow evaporation (m.p.
365 K). Analysis found (calculated) for C16H12O3: C 76.20 (76.18), H
4.75 (4.79)%.
Crystal data
C16H12O3
Mr = 252.26
Orthorhombic, Pbca
a = 11.1234 (5) A˚
b = 7.7504 (4) A˚
c = 28.4607 (11) A˚
V = 2453.62 (19) A˚3
Z = 8
Dx = 1.366 Mg m
3
Mo K radiation
 = 0.09 mm1
T = 173 (2) K
Plate, light yellow
0.38  0.21  0.19 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: none
31874 measured reflections
2813 independent reflections
2590 reflections with I > 2(I)
Rint = 0.049
max = 27.6

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.035
wR(F 2) = 0.092
S = 1.04
2813 reflections
173 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0462P)2
+ 0.6049P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.001
max = 0.22 e A˚
3
min = 0.15 e A˚3
Extinction correction: SHELXL97
Extinction coefficient: 0.033 (2)
Table 1
Selected torsion angles ().
C6—C8—C9—C10 178.11 (9)
O10—C10—C11—C16 151.40 (11)
C9—C10—C11—C16 27.79 (14)
O10—C10—C11—C12 25.96 (14)
C9—C10—C11—C12 154.85 (9)
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C1—H1A  O10i 0.99 2.59 3.0397 (14) 107
Symmetry code: (i) x 12;yþ 12;zþ 1.
H atoms were found in a difference map, but placed geometrically
and allowed to ride on their parent C atoms at distances of 0.95 and
0.99 A˚ for aromatic and methylene groups, respectively, and with
Uiso(H) = 1.2Ueq(C).
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97 and PLATON (Spek, 2003).
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Figure 1
The molecular structure of (I), with the atom numbering; displacement
ellipsoids are at the 50% probability level.
Figure 2
Packing diagram of the title compound, with a view approximately along
the b axis. Weak C—H  O hydrogen bonds are shown as dashed lines,
and H atoms not involved in these interactions have been omitted.
